COVID-19 and the new pragmatism

June 29, 2020
Previous Article
FSP and COVID-19: Impact on Clinical Trial Development
FSP and COVID-19: Impact on Clinical Trial Development

The functional service provider (FSP) outsourcing model enables sponsors to efficiently and cost-effectivel...

Next Article
Critical Global Pandemic Safety Considerations: FDA Expectations for Responding to Employees in Pharmaceutical Manufacturing Infected with C
Critical Global Pandemic Safety Considerations: FDA Expectations for Responding to Employees in Pharmaceutical Manufacturing Infected with C

On June 19, 2020, FDA released a Guidance for Industry (GFI) entitled Good Manufacturing Practice Considera...